A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
Titel:
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
Auteur:
Locati, L.D. Perrone, F. Cortelazzi, B. Bergamini, C. Bossi, P. Civelli, E. Morosi, C. Lo Vullo, S. Imbimbo, M. Quattrone, P. Dagrada, G.P. Granata, R. Resteghini, C. Mirabile, A. Alfieri, S. Orlandi, E. Mariani, L. Saibene, G. Pilotti, S. Licitra, L.